Gut Competition Dynamics of Live Bacterial Therapeutics Are Shaped by Microbiome Complexity, Diet, and Therapeutic Transgenes
Siguenza, N.; Bailey, S.; Sadegi, M.; Gootin, H.; Tiu, M.; Price, J. D.; Ramer-Tait, A.; Zarrinpar, A.
Show abstract
Competitive exclusion is conventionally believed to prevent the establishment of a secondary strain of the same bacterial species in the gut microbiome, raising concerns for the deployment of live bacterial therapeutics (LBTs), especially if the bacterial chassis is a strain native to the gut. In this study, we investigated factors influencing competition dynamics in the murine gut using isogenic native Escherichia coli strains. We found that competition outcomes are context-dependent, modulated by microbiome complexity, LBT transgene expression, intestinal inflammation, and host diet. Furthermore, we demonstrated that native LBTs can establish long-term engraftment in the gut alongside a parental strain, with transgene-associated fitness effects influencing competition. We identified various interventions, including strategic dosing and dietary modulation, that significantly enhanced LBT colonization levels by 2 to 3 orders of magnitude. These insights provide a framework for optimizing LBT engraftment and efficacy, supporting their potential translation for human therapeutic applications.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The gut commensal Blautia maintains colonic mucus function under low fiber consumption through short-chain fatty acid-mediated activation of Ffar2 96%
- Systemic Infection Facilitates Transmission of Pseudomonas aeruginosa 95%
- Postnatal intestinal epithelial maturation by LSD1 controls the small intestinal immune cell composition independently from the microbiota 95%
Similar papers in this journal
Similar papers in this journal
- Phage-delivered CRISPR-Cas9 for strain-specific depletion and genomic deletions in the gut microbiome 95%
- A diet-dependent host metabolite shapes the gut microbiota to protect from autoimmunity 94%
- Disruptions in cell fate decisions and transformed enteroendocrine cells drive intestinal tumorigenesis in Drosophila. 94%
Similar papers in this journal
- Failure of colonization following gut microbiota transfer exacerbates DSS-induced colitis 94%
- Microbial stimulation of oxytocin release from the intestinal epithelium via secretin signaling 94%
- Psychological stress disrupts intestinal epithelial cell function and mucosal integrity through microbe and host-directed processes 93%